OPKO Health, Inc.
OPKO Health, Inc. (OPK) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
opk · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for OPKO Health, Inc. (OPK) measures how much investors pay for each dollar of the company's trailing earnings. OPK's current PE ratio of N/A is calculated by dividing its stock price of $1.43 by its TTM earnings per share of -$0.28.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
OPKO Health, Inc.You OPK | $1.1B | N/A | — | -$0.28 |
 Claritev Corporation CTEV | $461M | N/A | — | -$17.30 |
 Dianthus Therapeutics, Inc. DNTH | $3.4B | N/A | — | -$4.30 |
 LifeMD, Inc. LFMD | $243M | N/A | — | -$0.16 |
 Nektar Therapeutics NKTR | $1.1B | N/A | — | -$9.73 |
 Oculis Holding AG OCS | $612M | N/A | — | -$1.81 |
 Pacira BioSciences, Inc. PCRX | $899M | 163.97x | — | $0.16 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.30 | — | |
2024-12-31 FY2024 | — | $-0.08 | — | |
2023-12-31 FY2023 | — | $-0.25 | — | |
2022-12-31 FY2022 | — | $-0.46 | — | |
2021-12-31 FY2021 | — | $-0.05 | — | |
2020-12-31 FY2020 | 82.74x | $0.05 | — | |
2019-12-31 FY2019 | — | $-0.53 | — | |
2018-12-31 FY2018 | — | $-0.27 | — | |
2017-12-31 FY2017 | — | $-0.55 | — | |
2016-12-31 FY2016 | — | $-0.10 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for OPKO Health, Inc. (OPK) measures how much investors pay for each dollar of the company's trailing earnings. OPK's current PE ratio of N/A is calculated by dividing its stock price of $1.43 by its TTM earnings per share of -$0.28.
Frequently asked questions
OPK pe ratio · 6 questionsOPK's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.43 and TTM EPS of -$0.28. Data sourced from Financial Modeling Prep via OPK's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · OPKO Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08